Sulfadiazine-Pyrimethamine Versus Sulfamethoxazole-Trimethoprim For Treatment of Toxoplasmic Encephalitis in Hiv/Aids Patients- A Cost Effectiveness Analysis
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.2911
https://www.valueinhealthjournal.com/article/S1098-3015(17)33245-X/fulltext
Title :
Sulfadiazine-Pyrimethamine Versus Sulfamethoxazole-Trimethoprim For Treatment of Toxoplasmic Encephalitis in Hiv/Aids Patients- A Cost Effectiveness Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)33245-X&doi=10.1016/j.jval.2017.08.2911
First page :
A930
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2678